1.A Retrospective Clinical Analysis of Multiple Myeloma Patients with Cardiac Amyloidosis.
Tian-Yue BIAN ; Shun WANG ; Qun LU ; Shi-Hui YUAN ; Rui LI ; Rui XU ; Ying CHEN ; Hua-Sheng LIU
Journal of Experimental Hematology 2025;33(3):834-840
OBJECTIVE:
To investigate the clinical characteristics, curative effect and prognostic factors of patients with multiple myeloma (MM) complicated with light chain myocardial amyloidosis (AL-CA).
METHODS:
The data of 38 patients diagnosed with MM complicated with AL-CA in our hospital from January 2018 to December 2023 were retrospectively analyzed, and the data were comprehensively screened by multiple methods such as positive two-dimensional spot tracking echocardiography (2D-STE). Survival analysis was performed using the Kaplan-Meier method. Cox regression models were used to screen for independent prognostic factors.
RESULTS:
Among the 38 MM patients with AL-CA, 23 were male and 15 were female, with a median age of 60(50,75) years. The 1-year survival rate was 71.05%. Patients who underwent transplantation had significantly better survival outcomes than those who did not (P < 0.01). Additionally, the median survival time of patients with all-negative FISH results at the first visit was statistically different compared to patients with other mutations (P < 0.05). Multivariate Cox regression analysis showed that all negative FISH results at the first visit and the absence of autologous hematopoietic stem cell transplantation (ASCT) were not independent risk factor for the prognosis of patients with MM and AL-CA (P >0.05).
CONCLUSION
ASCT may improve the prognosis of MM patients with AL-CA, and negative FISH results may indicate poor prognosis, but the results still need to be verified by larger samples.
Humans
;
Multiple Myeloma/complications*
;
Retrospective Studies
;
Aged
;
Female
;
Male
;
Middle Aged
;
Prognosis
;
Hematopoietic Stem Cell Transplantation
;
Amyloidosis/complications*
;
Survival Rate
;
Proportional Hazards Models
3.Renal Amyloidosis Secondary to ANCA-Associated Vasculitis: A Case Report.
He XIN ; Ning JIAN-PING ; Xu HUI ; Xiao GONG ; Yang HUI-XIANG ; Wang WEI-YUAN ; Wu XIAO-YING ; Yin HONG-LING ; Li XIAO-ZHAO
Chinese Medical Sciences Journal 2022;37(4):359-362
Renal amyloidosis secondary to anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is extremely rare. Here, we reported a 77-year-old woman with ANCA-associated vasculitis. Renal biopsy with Masson trichrome staining showed pauci-immune crescentic glomerulonephritis, and electron microscopy showed amyloid deposition in the mesangial area. Immunofluorescence revealed kappa light chain and lambda light chain negative. Bone marrow biopsy revealed no clonal plasma cell. Finally, she was diagnosed as ANCA-associated vasculitis with secondary renal amyloid A amyloidosis.
Female
;
Humans
;
Aged
;
Glomerulonephritis/diagnosis*
;
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/pathology*
;
Antibodies, Antineutrophil Cytoplasmic
;
Kidney/pathology*
;
Amyloidosis/complications*
4.Clinical Analysis of Patients with MGUS, Primary Light Chain Amyloidosis, Multiple Myeloma or Multiple Myeloma with Concurrent Amyloidosis.
Xue-Han MAO ; Shu-Hui DENG ; Wei-Wei SUI ; Ming-Wei FU ; Jia-Hui LIU ; Hui-Shou FAN ; De-Hui ZOU ; Yao-Zhong ZHAO ; Lu-Gui QIU ; Gang AN
Journal of Experimental Hematology 2021;29(3):812-818
OBJECTIVE:
To summarize and compare the clinical baseline characteristics of patients with monoclonal gammopathy of undetermined significance (MGUS), primary light chain amyloidosis (pAL), multiple myeloma (MM), or MM with concurrent amyloidosis, especially the differences in cytogenetic abnormalities.
METHODS:
The clinical data of 15 cases of MGUS, 34 cases of pAL, 842 cases of MM and 23 cases of MM with concurrent amyloidosis were analyzed and compared retrospectively.
RESULTS:
Cytogenetic statistics showed that the incidence of t (11; 14) in the four groups (MGUS vs pAL vs MM vs MM with concurrent amyloidosis) was 0%, 33.3%, 16.4%, and 15.8%, respectively (P=0.037); that of 13q deletion was 20.0%, 14.7%, 45.8% and 56.5%, respectively (P<0.001); gain of 1q21 was 50.0%, 12.5%, 47.4% and 40.9%, respectively (P=0.001). Proportion of pAL patients with 0, 1 and≥2 cytogenetic abnormalities (including 13q deletion, 17p deletion, 1q21 amplification and IgH translocation) accounted for 41.9%, 41.9% and 16.1%, respectively; while the proportion of the same category in MM was 17.6%, 27.3%, and 55.2% respectively; this ratio of MM with concurrent amyloidosis was more similar to MM. Subgroup analysis showed that genetic abnormalities (including 13q deletion, 17p deletion and 1q21 amplification) were comparable within t (11; 14) negative and positive groups. Compared with positive cases, t(11; 14) negative patients with MM or MGUS were more likely to have 13q deletions and multiple genetic abnormalities.
CONCLUSION
Clinical characteristics of pAL, especially cytogenetic abnormalities, are significantly different from MM with concurrent amyloidosis. It suggests that although the onset characteristics are similar, actually the two diseases belong to different disease subtypes which should be carefully predicted and identified.
Amyloidosis
;
Humans
;
In Situ Hybridization, Fluorescence
;
Monoclonal Gammopathy of Undetermined Significance/complications*
;
Multiple Myeloma
;
Retrospective Studies
6.A Case of Primary Gastric Amyloidosis with Fulminant Heart Failure.
Seonghun HONG ; Young Woon CHANG ; Jong Kyu BYUN ; Min Je KIM ; Jung Min CHAE ; Sun Hee PARK ; Chi Hyuk OH ; Yong Koo PARK
The Korean Journal of Gastroenterology 2015;66(4):227-230
A 53-year-old woman was admitted with epigastric discomfort and weakness. Laboratory examination at admission showed mild anemia and proteinuria. Esophagogastroduodenoscopy revealed marked mucosal atrophy, diffuse nodularity and granular appearance with mucosal friability. Biopsy was performed on the antrum and body of the stomach. On the next day, the patient began to complain of severe dyspnea, and hypoxia was present on pulse oximetry. Therefore, emergency echocardiography was conducted and it showed restrictive cardiomyopathy along with thrombus in the left atrium. With time, heart failure was aggravated despite intensive management. The result of gastric biopsy revealed amyloid deposits which stained positively with Congo red. On immunohistochemistry study, kappa and lambda chain were present. In addition, kappa chain was significantly elevated in urine and serum on electrophoresis. Although the patient was finally diagnosed as having primary gastric amyloidosis with restrictive cardiomyopathy, her general condition rapidly deteriorated and died at 12th hospital day. When obscure gastric lesion is encountered, performing gastric biopsy is strongly recommended since it be primary gastric amyloidosis. Herein, we present an unusual case of primary gastric amyloidosis.
Amyloidosis/complications/*diagnosis/pathology
;
Endoscopy, Digestive System
;
Female
;
Heart Atria/diagnostic imaging
;
Heart Failure/complications/*diagnosis
;
Humans
;
Immunoglobulin kappa-Chains/blood/urine
;
Immunoglobulin lambda-Chains/blood/urine
;
Immunohistochemistry
;
Magnetic Resonance Imaging
;
Middle Aged
;
Stomach Diseases/complications/*diagnosis/pathology
;
Thrombosis/diagnosis/diagnostic imaging
;
Tomography, X-Ray Computed
;
Ultrasonography
7.Localized Thymic Amyloidosis Presenting with Myasthenia Gravis: Case Report.
Seung Myoung SON ; Yong Moon LEE ; Si Wook KIM ; Ok Jun LEE
Journal of Korean Medical Science 2014;29(1):145-148
A mediastinal mass was incidentally found on chest radiography in a 46-yr-old woman who had had myasthenia gravis (MG) for 2 months. Computed tomography revealed a 4-cm in size, well-defined, and lobulating mass with nodular calcification that was located in the thymus. Microscopically, the mass consisted of diffuse amorphous eosinophilic materials. These deposits exhibited apple-green birefringence under polarized light microscopy after Congo red staining. Immunohistochemical analysis revealed that they were positive for both kappa and lambda light chains and negative for amyloid A. A diagnosis of localized primary thymic amyloidosis was finally made. After thymectomy, the symptoms of MG were controlled with reduced corticosteroid requirements. Localized thymic amyloidosis associated with MG has not been reported to date.
Amyloidosis/complications/*radiography/*surgery
;
Calcinosis/*radiography/*surgery
;
Female
;
Humans
;
Immunoglobulin kappa-Chains/immunology
;
Immunoglobulin lambda-Chains/immunology
;
Mediastinum/radiography/surgery
;
Middle Aged
;
Myasthenia Gravis/*complications
;
Radiography, Thoracic
;
Thymectomy
;
Thymus Gland/radiography/surgery
;
Tomography, X-Ray Computed
9.A case of systemic amyloidosis beginning with purpura.
Jun-Ying ZHAO ; Rui-Na ZHANG ; Xiao-Han DUAN ; Zhi-Li XU ; Hong-Wei LI ; Fu-Sheng GU
Chinese Medical Journal 2012;125(3):555-557
Primary systemic amyloidosis is a relatively rare disease, caused when abnormal extracellular deposition of fibrillary protein builds up in a variety of target organs, such as heart, kidneys, lungs liver, and so forth. The symptoms of the disease are usually vague, while many kinds of auxiliary or laboratory examinations especially pathologic biopsy can provide a clue for the diagnosis. Here we described a case who had purpura-like lesions in the initial stage, followed by progressive malfunctions in the kidneys, the heart, the lungs, as well as the liver. The final diagnosis was primary systemic amyloidosis determined by skin pathologic biopsy. And the disease led to a fatal outcome within three months after the diagnosis.
Amyloidosis
;
complications
;
diagnosis
;
diagnostic imaging
;
Female
;
Humans
;
Middle Aged
;
Purpura
;
diagnostic imaging
;
etiology
;
pathology
;
Ultrasonography

Result Analysis
Print
Save
E-mail